[Retracted] Serum Level of CEACAM1 in Patients with Nonsmall Cell Lung Cancer and Its Clinical Significance in Cancer Tissue

Table 1

Comparison of serum indicators between NSCLC patients and healthy subjects (X ± S).

Group	Cases	CEACAM1 (ng/mL)	TGF-β (ng/mL)	VEGF-A (ng/mL)	IL-8 (ng/mL)
NSCLC groups	100	37.9 ± 14.1	31.7 ± 12.6	553.5 ± 165.6	1.5 ± 0.6
Health groups	100	0.6 ± 0.2	10.7 ± 10.8	116.7 ± 20.8	0.4 ± 0.1
t		9.47	7.67	14.10	12.41
value		≤0.001	≤0.001	≤0.001	≤0.001